Plasma protein C levels in children with sickle cell disease

American Journal of Pediatric Hematology/Oncology

Volumn 11, Issue 3, 1989, Pages 320-323

  Karayalcin, Gungor ^a,b   Lanzkowsky, Philip ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Protein C; Sickle cell disease; Vasooclu sive crisis

Indexed keywords

PROTEIN C;

ADOLESCENT; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; HUMAN; LIVER FUNCTION; RISK; SICKLE CELL ANEMIA; THROMBOSIS; VEIN OCCLUSION;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD COAGULATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; INFANT; MALE; PROTEIN C;

EID: 0024366707     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Green D, Kwaan HC, Ruiz G. Impaired fibrinolysis in sickle cell disease. Relation to crisis and infection. Thromb Diath Haemorrh 1970;24:10-6.
2. Gordon PA, Breeze GR, Mann JR, Stuart J. Coagulation and fibrinolysis in sickle cell disease. J Clin Pathol 1974;27: 485-9.
3. Ittyerah R, Alkjaersig N, Fletcher A, Chaplin H. Coagulation and factor XIII concentration in sickle cell disease. J Lab Clin Med 1976;88:546-54.
4. Leichtman DA, Brever G. Elevated plasma levels of fibrin- opeptide A during sickle cell anemia pain crisis-Evidence for intravascular coagulation. Am J Hematol 1978;5:183-90.
5. Stuart MJ, Stockman JA, Oski FA. Abnormalities of platelet aggregation in the vaso-occlusive crisis of sickle cell anemia. J Pediatr 1974;85:629-32.
6. Gruppo RA, Glueck HI, Granger SM, Miller MA. Platelet function in sickle cell anemia. Throm Res 1977;10:325-35.
7. Richardson SGN, Mathews KB, Stuart J, et al. Serial changes in coagulation and viscosity during sickle cell crisis. Br J Haematol 1979;41:95-103.
8. Mehta P. Significance of plasma beta-thromboglobulin values in patients with sickle cell disease. J Pediatr 1980;97: 941-3.
9. Karayalcin G, Lanzkowsky P, Stem B, Santiago A. Plasma antithrombin III activity in children with sickle cell disease. Blood 1979;54(5):285.
10. Karayalcin G, Chung D, Lanzkowsky P. Plasma antithrombin III levels in children with homozygous sickle cell disease. Pediatr Res 1984;18:242a.
11. Griffin JH, Evatt B, Zimmerman TS, et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68(5): 1370-3.
12. Bertina RM, Broekmans AW, van der Linden IK, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemost 1982;48(l):l-5.
13. Esmon CT. Protein C: Biochemistry, physiology and clinical implications. Blood 1983;62:1155-8.
14. Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. N Engl J Med 1983;309(6):340-4.
15. Vicente V, Maia R, Alberca I, et al. Congenital deficiency of vitamin K-dependent coagulation factors and protein C. Thromb Haemost 1984;51:343-6.
16. Seligsohn U, Berger A, Abend M, et al. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. New Engl J Med 1984;310:559-62.
17. Sills RH, Marlar RA, Montgomery RR, et al. Severe ho-mozygous protein C deficiency. J Pediatr 1984;105:409-13.
18. Marciniak E, Wilson HD, Marlar RA. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood. Blood 1985;65:15-20.
19. Diggs LW. Sickle cell crises. Am J Clin Pathol 1965;44:1-19.
20. Green TW, Conley CL, Bethrong M. The liver in sickle cell anemia. Bull Johns Hopkins Hosp 1953;92:99-122.
21. Mannucci PM, Vigano S. Deficiencies of protein C, an in hibitor of blood coagulation. Lancet 1982;2:463-7.
22. Murphy RC, Shapiro S. Pathology of sickle cell disease. Ann Intern Med 1945;23:376-97.
23. Salvagio JE, Arnold CA, Barrow CH. Long-term anticoagulants in sickle cell disease. Clinical study. N Engl J Med 1963;269:182-6.
24. Vigano S, Mannucci PM, Solinas S, et al. Early fall of protein C during short-term anticoagulant therapy. Thromb Haemost 1983;50:310.
25. McGehee WG, Klotz TA, Epstein DJ, Rappaport SI. Coumarin necrosis associated with hereditary protein C de-ficiency. Ann Intern Med 1984;101:59-60.
26. Comp P, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein into dogs. J Clin Invest 1981; 68:1221-8.